Jiyan Liu

机构：Sinopec (China), Sichuan University, Jianghan University, West China Hospital of Sichuan University, Shandong Mental Health Center, Sichuan Cancer Hospital, Guangdong Food Industry Research Institute, Shandong Center for Disease Control and Prevention, SINOPEC Research Institute of Safety Engineering Co., Ltd. · ORCID：0000-0003-4885-5481

发表论文 297 篇 · 总被引 4698 次 · h-index 34

代表论文

• Innovative Nanomedicine Delivery: Targeting Tumor Microenvironment to Defeat Drug Resistance (2024 · Pharmaceutics · 被引 45)
• CD44 on cancer stem cell is a potential immunological and prognostic pan-cancer biomarker (2025 · Cancer Cell International · 被引 15)
• Mitochondrial metabolic reprogramming of macrophages and T cells enhances CD47 antibody-engineered oncolytic virus antitumor immunity (2024 · Journal for ImmunoTherapy of Cancer · 被引 15)
• Comprehensive molecular profiling of FH-deficient renal cell carcinoma identifies molecular subtypes and potential therapeutic targets (2025 · Nature Communications · 被引 14)
• Epigenetic modifications in breast cancer: from immune escape mechanisms to therapeutic target discovery (2025 · Frontiers in Immunology · 被引 13)
• Camrelizumab plus apatinib for previously treated advanced adrenocortical carcinoma: a single-arm phase 2 trial (2024 · Nature Communications · 被引 13)